Literature DB >> 21493907

Measurement of cerebrovascular reactivity in pediatric patients with cerebral vasculopathy using blood oxygen level-dependent MRI.

Jay S Han1, David J Mikulis, Alexandra Mardimae, Andrea Kassner, Julien Poublanc, Adrian P Crawley, Gabrielle A deVeber, Joseph A Fisher, William J Logan.   

Abstract

BACKGROUND AND
PURPOSE: Cerebrovascular reactivity (CVR) is an indicator of cerebral hemodynamics. In adults with cerebrovascular disease, impaired CVR has been shown to be associated with an increased risk of stroke. In children, however, CVR studies are not common. This may be due to the difficulties and risks associated with current CVR study methodologies. We have previously described the application of precise control of end-tidal carbon dioxide partial pressure for CVR studies in adults. Our aim is to report initial observations of CVR studies that were performed as part of a larger observational study regarding investigations in pediatric patients with cerebral vascular disease.
METHODS: Thirteen patients between the ages of 10 and 16 years (10 with a diagnosis of Moyamoya vasculopathy and 3 with confirmed, or suspected, intracranial vascular stenosis) underwent angiography, MRI, and functional blood oxygen level-dependent MRI mapping of CVR to hypercapnia. The results of the CVR study were then related to both the structural imaging and clinical status.
RESULTS: Sixteen blood oxygen level-dependent MRI CVR studies were performed successfully in 13 consecutive patients. Twelve of the 13 patients with angiographic abnormalities also had CVR deficits in the corresponding downstream vascular territories. CVR deficits were also seen in 8 of 9 symptomatic patients and 2 of the asymptomatic patients. Notably, in patients with abnormalities on angiography, the reductions in CVR extended beyond the ischemic lesions identified with MR structural imaging into normal-appearing brain parenchyma.
CONCLUSIONS: This is the first case series reporting blood oxygen level-dependent MRI CVR in children with cerebrovascular disease. CVR studies performed so far provide information regarding hemodynamic compromise, which complements traditional clinical assessment and structural imaging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493907     DOI: 10.1161/STROKEAHA.110.603225

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  Developmental trajectories of cerebrovascular reactivity in healthy children and young adults assessed with magnetic resonance imaging.

Authors:  Jackie Leung; Przemyslaw D Kosinski; Paula L Croal; Andrea Kassner
Journal:  J Physiol       Date:  2016-03-17       Impact factor: 5.182

2.  Reproducibility of a ramping protocol to measure cerebral vascular reactivity using functional magnetic resonance imaging.

Authors:  Nicholas G Evanoff; Bryon A Mueller; Kara L Marlatt; Justin R Geijer; Kelvin O Lim; Donald R Dengel
Journal:  Clin Physiol Funct Imaging       Date:  2020-02-16       Impact factor: 2.273

3.  Functional and anatomical evidence of cerebral tissue hypoxia in young sickle cell anemia mice.

Authors:  Lindsay S Cahill; Lisa M Gazdzinski; Albert Ky Tsui; Yu-Qing Zhou; Sharon Portnoy; Elaine Liu; C David Mazer; Gregory Mt Hare; Andrea Kassner; John G Sled
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

4.  Cerebrovascular reactivity and white matter integrity.

Authors:  Kevin Sam; Boris Peltenburg; John Conklin; Olivia Sobczyk; Julien Poublanc; Adrian P Crawley; Daniel M Mandell; Lakshmikumar Venkatraghavan; James Duffin; Joseph A Fisher; Sandra E Black; David J Mikulis
Journal:  Neurology       Date:  2016-10-28       Impact factor: 9.910

5.  A case study of magnetic resonance imaging of cerebrovascular reactivity: a powerful imaging marker for mild traumatic brain injury.

Authors:  Suk-tak Chan; Karleyton C Evans; Bruce R Rosen; Tian-yue Song; Kenneth K Kwong
Journal:  Brain Inj       Date:  2014-11-10       Impact factor: 2.311

6.  Assessing cerebrovascular reactivity abnormality by comparison to a reference atlas.

Authors:  Olivia Sobczyk; Anne Battisti-Charbonney; Julien Poublanc; Adrian P Crawley; Kevin Sam; Jorn Fierstra; Daniel M Mandell; David J Mikulis; James Duffin; Joseph A Fisher
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-12       Impact factor: 6.200

Review 7.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

8.  Predicting Ischemic Risk Using Blood Oxygen Level-Dependent MRI in Children with Moyamoya.

Authors:  N Dlamini; M Slim; F Kirkham; M Shroff; P Dirks; M Moharir; D MacGregor; A Robertson; G deVeber; W Logan
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-05       Impact factor: 3.825

9.  Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.

Authors:  Travis R Ladner; Manus J Donahue; Daniel F Arteaga; Carlos C Faraco; Brent A Roach; L Taylor Davis; Lori C Jordan; Michael T Froehler; Megan K Strother
Journal:  J Neurosurg       Date:  2016-03-11       Impact factor: 5.115

10.  The effects of propofol on cerebral perfusion MRI in children.

Authors:  Julie H Harreld; Kathleen J Helton; Roland N Kaddoum; Wilburn E Reddick; Yimei Li; John O Glass; Rakhee Sansgiri; Qing Ji; Tianshu Feng; Mary Edna Parish; Amar Gajjar; Zoltan Patay
Journal:  Neuroradiology       Date:  2013-05-15       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.